Investors step up calls to cut use of antibiotics in food chain

The article discusses how investors managing more than $13 trillion in combined assets have signed a statement urging global leaders and policymakers to act against the spread of AMR, This call is the latest of a series of actions led by the IAAMR initiative, established in 2020 by the the Access to Medicine Foundation, the FAIRR investor network, and the UK Department of Health and Social Care. This initiative focuses on the role of capital markets in tackling the global threat of rising drug-resistant infections. 

The 80 investor signatories call on global leaders and policymakers to help curb drug-resistant superbugs by cutting the excessive use of antibiotics. The article cites the IAAMR and indicates that the global costs linked to AMR could potentially hit $100 trillion, resulting in a projected 3.8 percent decline in global GDP by 2050.